Neuren Pharmaceuticals | NEU - Sales Revenues

Stock Price
13.19
Daily Change
-0.26 -1.90%
Monthly
-22.89%
Yearly
-0.34%
Q1 Forecast
12.80

Neuren Pharmaceuticals reported AUD14.14M in Sales Revenues for its fiscal semester ending in June of 2025.





Sales Change Date
Akebia Therapeutics USD 57.34M 10.84M Mar/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 18.42M 14K Jun/2025
Clinuvel Pharmaceuticals AUD 55.92M 23.66M Jun/2024
Dianthus Therapeutics USD 396K 203K Sep/2025
Genetic Signatures AUD 5.63M 1.26M Jun/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
Medical Developments International AUD 9.53M 1.99M Jun/2025
Neuren Pharmaceuticals AUD 14.14M 179.96M Jun/2025
Organon & Co USD 1.51B 90M Dec/2025
Paradigm Biopharmaceuticals AUD -8K 441.66K Jun/2025
PYC Therapeutics AUD 13.48M 786.97K Jun/2025
Starpharma Holdings AUD 1.71M 717K Jun/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025
Viatris USD 3.7B 60M Dec/2025
Xeris Pharmaceuticals USD 74.38M 2.84M Sep/2025